Health ❯ Healthcare ❯ Medical Research ❯ Oncology

Breast Cancer

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

Preliminary matched data presented at SABCS point to a personalized option for women facing surgical menopause after risk-reducing ovary removal.

Phase II Trial Finds 24 Gy Preoperative Radiation With Pembrolizumab Boosts T‑Cell Infiltration in HR+/HER2− Breast Cancer

Preoperative MRI Fails to Improve Outcomes in Early HR-Negative Breast Cancer

Tucatinib Added to First-Line HER2 Maintenance Prolongs Progression-Free Survival in Phase 3 Trial

AI Multimodal Model Outperforms Oncotype DX for Long-Term Breast Cancer Recurrence Risk

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Roche’s Giredestrant Plus Everolimus Extends PFS in Phase 3 evERA for ER-Positive, HER2-Negative Breast Cancer

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

NF1-Low ER+ Breast Cancers Identified as Likely Responders to CDK4/6 Inhibitors

Celcuity’s Gedatolisib Combos Yield Up to 76% Progression-Free Survival Gain in Phase 3 Trial

Low-Dose Vitamin D Supplementation Enhances Chemotherapy Success in Breast Cancer Trial